Recent work on obesity-associated variants in the dioxygenase FTO [102] highlights this and illustrates further approaches that can be used to investigate GWAS signals and the functional significance of regulatory variants. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.